Coronary heart disease or ischaemic heart disease may be defined as coronary arterial disease that results in dysfunction of the heart. Well-recognized presentations are angina pectoris on effort, coronary insufficiency, which may be defined as cardiac pain at rest without the stigmata of cardiac infarction, and cardiac infarction itself, which may be silent. In recent years the cardiac dysrhythmias have been increasingly recognized as initial manifestations of coronary heart disease. A number of patients present with sudden death, and some with cardiomegaly. The last is particularly common in old age.
RISK FACTORS
The following factors are recognized as placing people at an undue risk of the likelihood of developing the disease. One of the foremost is a first-degree affected relative with the disease (Cassidy, 1946; Gertler and White, 1954; Thomas and Cohen, 1955; Rose, 1964; Slack and Evans, 1966) ; an important correlation in this respect is an impairment of lipoprotein lipase (Slack et al., 1964) . The disease is predominantly one of the male sex (Heberden, 1802; Hedley, 1939) , though women after the menopause and after bilateral ovariectomy (Oliver and Boyd, 1959) have the same risk. Hypercholesterolaemia (Gertler, Garn, and Lerman, 1950) crudely reflects the abnormality of lipid metabolism, which is more accurately shown by hyperglyceridaemia (Antonis and Bersohn, 1960) . Systemic hypertension is an important contributory cause (Dawber, Moore, and Mann, 1957; Kannel et al., 1961; Dawber et al., 1962) , and abnormal carbohydrate metabolism is increasingly recognized as such (Wahlberg, 1962) . Abnormalities of platelet behaviour, such as platelet stickiness, also seem important (McDonald and Edgill, 1957) ; a * The St. Cyres Lecture of the National Heart Hospital delivered at the Royal College of Physicians, London, November 30, 1966. number of patients have been studied in whom platelet behaviour has been abnormal for periods varying from two years to a few weeks before the development of cardiac infarction (L. McDonald, 1966, unpublished data) . The role of cigarette smoking (Doll and Hill, 1954; Hammond and Horn, 1954) seems certain.
Possible risk factors which have been incriminated by various authors include diet, with an unduly heavy intake of animal fat, sugar, and also protein. Furthermore, those who have large heavy meals have been thought more likely to develop the disease, together with the overweight and the physically inactive. Hyperuricaemia has during recent years become apparent as a risk factor; its possible role was recognized by Allbutt (1915) . Kohn and Prozan (1959) found that 70 per cent of patients with cardiac infarction had a raised serum uric acid. Morris, Crawford, and Heady (1961) found that the disease was more prevalent in areas where there was soft as opposed to hard water, and Bi6rck, Bostr6m, and Widstrom (1965) found an important and highly significant negative correlation between calcium ion concentration in the water and the statistical group 422 which is " other degenerative heart disease". In the Framingham study it was shown that if a person developed cardiac infarction the spouse was more likely to do so (Dawber et al., 1957) . Most of these risk factors apply to groups, and the more precise identification of the person likely to develop ischaemic heart disease seems important.
Occupational risk does appear to produce the possibility of acquired factors. Occupational mortality has been studied by Morris (1962) using the standardized mortality ratio of various groups of occupations (Fig. 1) . These ratios are ratios of the national average rate, allowances having been made for differences in age structure and between occupations. The occupation at highest risk was that of the radio and telegraph operators, whose risk rate England and Wales, 1949-53. (a) Occupations with the highest mortality; (b) those with the lowest mortality. (From Morris, 1962.) was more than twice normal. Denominational differences appeared to exist: Roman Catholic priests were found to be more likely to develop ischaemic heart disease than clergymen of the Church of England. Doctors also appeared with a high risk rate. The occupations with the lowest risk rates are shown in Fig. 1 , the lowest being that of rag, bone, and bottle sorters.
Figures from the London Hospital and the National Autopsy Survey (Morris, 1951; Morris and Crawford, 1961) suggest that it may be thrombosis, as opposed to disease of the arterial wall, that is important in the claimed increase in the incidence of cardiac infarction (Table I) .
THROMBOSIS
It is important, in considering thrombosis in ischaemic heart disease, to differentiate between thrombus-formation and clotting (Poole and French, 1961) . A thrombus occurs in vivo, and has a complicated structure of agglutinated platelets and leucocytes, the so-called "white head", to which is attached a meshwork of fibrin with entrapped red cells, which has been called the "red tail". A clot, on the other hand, occurs in vitro, and its structure is uniform; all the blood cells including the platelets Per cent Davenport (1928) 60 Barnes and Ball (1932) 69 Gross and Stemnberg (1939) 7 Blumgart et al. (1940) 90 Master et al. (1941) 0 Master et al. (1944) 96 Harrison and Wood (1949) 93 Snow et al. (1955) 59 Muri (1956) 94 Spain and Bradess (1960) 16-54 Harland and Holburn (1966) 91 * Modified from Mitchell and Schwartz (1965). coronary arteries into occlusion thrombi, recanalizing thrombi, and arterial plaques. They quoted Duguid (1946 Duguid ( , 1948 regarding the difficulty in distinguishing between occluding plaques and recanalizing thrombi, and noted that the difference was probably artificial. The reported incidence of thrombosis in cardiac infarction (Table II) varies from 0 to 96 per cent (Davenport, 1928; Barnes and Ball, 1932; Gross and Stemnberg, 1939; Blumgart, Schlesinger, and Davis, 1940; Master et al., 1941 Master et al., , 1944 Harrison and Wood, 1949; Snow, Morgan Jones, and Daber, 1955; Muri, 1956; Spain and Bradess, 1960; Harland and Holburn, 1966) . Questions arise as to whether authors have differed in their selection of cases, in the techniques and thoroughness of their examinations, and even regarding the possible misinterpretation of data. Muri (1956) , in an excellent study, found only 2 of 33 cases that did not have evidence of a fresh thrombotic occlusion, and Harland and Holburn (1966) reported thrombosis in 91 per cent of cases of cardiac infarction. At the very least, thrombosis is important in a small group of cases only, but it is probably so in the vast majority. It may even play an important role in the development of the changes described as atherosclerosis, and it seems a likely final common path of many risk factors. Mitchell and Schwartz (1965) wrote: "It is possible, therefore, that there is an alternative explanation for the observed relationship between the wall disease and thrombosis: thrombi begin to form at certain sites in the coronary tree, as determined by blood flow patterns and this process beginning before the age of 35 in men and at a later age in women. In the majority of patients these thrombi are non-occlusive or, if occlusion occurs, it does so when collateral channels are still adequate. These thrombi then organise into wall plaques, and when further thrombi form, they will do so in similar sites, as the haemodynamic factors responsible for the first thrombus are still operating, and may indeed be exaggerated by the wall disease; thus thrombi and plaques will appear to be related anatomically. When occluding thrombi form in patients whose arterial collateral zone has been reduced by previous thrombotic episodes, cardiac necrosis will occur, and only at this stage will the process, which may have been proceeding steadily for years, declare itself. Although purely hypothetical, this concept is in accordance with the observations. Moreover, there is no evidence for the present view that thrombosis is the result of wall disease, whereas there is good evidence from Rokitansky (1852), Clark et al. (1936) and Duguid (1946) as well as from our survey that wall disease can result in thrombosis. We suggest, therefore, that the adoption of the hypothesis set out above as a basis for future studies, might advance our knowledge more rapidly by focusing attention on the circulating blood, rather than on the vessel wall lesions, which may be the result and not the cause of thrombosis. "
It seems, therefore, that changes in the flowing blood may be of prime importance in ischaemic heart disease, and more so than the changes in the arterial wall which have been so extensively studied.
Coagulation Sequence. What evidence exists for changes in the flowing blood in this disease ? Fig. 2 shows a broad outline of the sequence of events that may occur when flowing blood comes into contact with a foreign surface, leading to the formation of fibrin, and various tests of blood coagulation and thrombosis that may reflect these changes.
INVESTIGATION OF THROMBoSIS
Methods of studying thrombosis have lagged considerably behind those for the study of blood coagulation in relation to the bleeding disorders; four will be considered. These are Wright's (1941) method of studying platelet stickiness, in which the tendency of platelets to stick to glass is studied; platelet turnover using radioactive phosphorus, which measures platelet survival, and has been used group.bmj.com on December 23, 2017 -Published by http://heart.bmj.com/ Downloaded from extensively by Mustard ); Born's (BoM and Cross, 1963) method of studying platelet aggregation, which reflects the tendency of platelets to adhere to one another; and Chandler's (1958) method. In the last there is the unusual situation that a structure very like a thrombus is produced in vitro; blood that is circulated in a rotating wheel is observed and the rate of thrombus formation and the microscopical structure of the "thrombus" examined. It differs, however, in at least one important aspect from thrombosis in vivo, in that the arterial endothelium is lacking from the preparation.
In Wright's (1942) original study, platelet stickiness was found to be increased 7 to 10 days after parturition and major operations, at which time it is recognized that intravascular thrombosis is likely to occur. A small amount of blood is placed (Wright, 1941) , after a minimal amount of heparin has been added, in a glass bulb (Fig. 3A) . This is rotated, usually for a period of 20 minutes, on a wheel (Fig. 3B) ; our initial work (McDonald and Edgill, 1957) was done on this appratus.
In Born's method of studying platelet aggregation, platelet rich plasma is rapidly stirred by an electromagnet, and is placed between a light source and a photocell. Changes in optical density are recorded on a galvanometer. Fig. 4A shows the laboratory apparatus, with the light source, photocell, water bath, and galvanometer. Used in this way, aggregating substances have been found to be adenosine diphosphate (ADP), whose action was noted by Gaarder et al. in 1961, adenosine triphosphate (Mitchell and Sharp, 1964) , though this has subsequently been queried by O'Brien (1962) and its action may be due to its breakdown into diphosphate, and 5-hydroxytryptamine, adrenaline, and noradrenaline (Mitchell and Sharp, 1964) . Other studies have shown that thrombin (Schmid, Jackson, and Conley, 1962) may have this effect, as well as certain fatty acids (Hoak, Poole, and Robinson, 1963) and collagen (Zucker and Borrelli, 1962) . A likely conclusion is that a final common path for all these aggregating substances is adenosine diphosphate (Haslam, 1964) .
Furthermore, if adenosine diphosphate accumulation is prevented by the pyruvate kinase and the 2-phosphoenol pyruvate system, then the aggregating ability of thrombin and fatty acids is inhibited (Haslam, 1964) . In addition, adenosine and related substances have the ability to inhibit adenosine diphosphate-induced aggregation (Born et al., 1965) , antiserotonin compounds to inhibit aggregation induced by 5-hydroxytryptamine, and phentolamine to inhibit that induced by adrenaline and noradrenaline (O'Brien, 1964) . The possible importance of (A) (13) 
FIG. 3.-(A) Glass bulb used in platelet stickiness test. (B)
Rotating wheel used by Wright (1942) in the estimation of platelet stickiness.
these substances in inhibiting thrombosis will be considered later. Fig. 4B shows normal platelet aggregation using Born's method. Optical density is altered, by the addition of the nucleotides in various concentrations, during the early minutes after the addition of the nucleotide. Fig. 5 shows the apparatus used in Chandler's (1958) method; a plastic tube containing blood is placed on a rotating wheel. A protractor is fixed to the wheel to measure various parameters, and the whole is driven by an electric motor.
Studies of Platelet Stickiness. In studying mechanisms which may relate to thrombosis, in the blood of patients with ischaemic heart disease and apparently healthy controls, the importance of studying patients and controls with these methods cannot be overemphasized, as absolute values are probably less important than the comparison between normality and patients who have the disease. After an initial study (McDonald and Edgill, 1957) between patients with ischaemic heart disease and controls, which showed platelet stickiness, fibrinogen levels, and thromboplastin generation to be significantly increased and which demonstrated hypercoagulability of the blood in the patients, the findings in patients in different stages of the disease and in controls were investigated (McDonald and Edgill, 1959) . The different stages of ischaemic heart disease were angina pectoris on exertion, acute coronary insufficiency (Master, Jaffe, and Pordy, 1954) , and recent cardiac infarction. Significant differences (at the 0 01 level) were shown between platelet stickiness in controls and patients (Fig. 6) , and in comparing those with angina pectoris with those who had a recent cardiac infarction, there was a further significant increase in platelet stickiness. In this respect the patients with acute coronary insufficiency behaved similarly to those with angina pectoris.
One of the two controls with the most abnormal platelet stickiness developed cardiac infarction two years later. Other instances now exist of patients in whom platelet behaviour was abnormal before the development of cardiac infarction. A physician who had a cardiac infarction had repeatedly studied group.bmj.com on December 23, 2017 -Published by http://heart.bmj.com/ Downloaded from his own blood platelets over the preceding year, and they were consistently abnormal. It is entirely possible that in population studies abnormal platelet stickiness might not be apparent before cardiac infarction; it seems, from our repeated studies on patients and controls over the years, that the change in the platelets may be of comparatively short duration. Findings on abnormal platelet stickiness in ischaemic heart disease have been confirmed in different countries, particularly by T. R. E. Pilkington (1960, personal communication) and by Nestel (1961) .
A similar change in platelet behaviour has been described in patients with recurrent venous thrombosis and pulmonary embolism (Hirsh and McBride, 1965;  Thomas, Gurewich, and Ashford, 1966) . Besterman, Myat, and Travadi (1967) have recently confirmed the difference in platelet stickiness between patients and controls (significant at the 0 01 level in their experience), and have shown an interesting and significant diurnal variation in platelet stickiness, with an increase towards the end of the day. Further, they studied the possibility, with experimental evidence, of a link in platelet behaviour and catecholamine excretion. Evans and Irvine (1966) have made observations on patients with arterial grafts, which lend important weight to the possibility of platelet behaviour being abnormal before the onset of arterial thrombosis. They found that increased platelet stickiness was accompanied by a much reduced likelihood of long-term patency in arterial grafts.
The pattern with regard to fibrinogen levels Edgill, 1957, 1959 ) was similar to thit of platelet stickiness, with a significant increase at the 0 01 level between the controls and the patients, and the difference between the patients and controls was most marked after recent cardiac infarction. A similar pattern existed in thromboplastin generation with the same significant difference.
Causes ofAbnormal Platelet Stickiness. As a result of preliminary investigations the behaviour of the blood platelets in ischaemic heart disease seemed to merit further study; and, of prime importance was the question as to what was the cause of abnormal platelet stickiness. Accordingly, levels of the enzyme lipoprotein lipase were determined in patients with ischaemic heart disease and in normal men who acted as controls, and were related to platelet behaviour (Slack et al., 1964) (Fig. 7) . Lipoprotein lipase activity was significantly lower (p < 0 001) in the men with ischaemic heart disease than in the normal subjects, and the difference between the activity of the enzyme in all men with an affected first-degree relative and all men with no affected first-degree relative was similarly significant. Further, the mean level of lipoprotein lipase activity in the controls with an affected first-degree relative was nearer to the mean level of all the patients, than to the controls with no affected first-degree relative. Thus, it was apparent that lipoprotein lipase might be concerned in the aetiology of ischaemic heart disease, and the presence of a genetic factor in the enzyme deficiency seemed likely. When platelet stickiness and lipoprotein lipase were compared in the controls (Fig. 8) there was a highly significant correlation between platelet stickiness and lipoprotein lipase in the controls (p < 0 001). A less significant correlation existed between platelet stickiness and lipoprotein lipase in the patients with ischaemic heart disease. Thus, a correlation was shown between decreasing lipoprotein lipase activity and increasing stickiness of the blood platelets, which was more significant in the normal men than in the men with ischaemic heart disease. Since patients with ischaemic heart disease have increased platelet stickiness and diminished lipoprotein lipase activity, any correlation between these in the patients may be fortuitous. In normal men, however, the significance of the relation between lipoprotein lipase activity and platelet stickiness is real, since the common factor of overt ischaemic heart disease is lacking. A study of homocystinuria ) is relevant to ischaemic heart disease. In homocystinuria there appears to be a metabolic block in the chain of events, methionine --homocystine --cystathione, and subsequently the levels of plasma and urinary homocystine are raised. The disease is characterized by arterial and venous thromboses in childhood and early life. These children present with various somatic abnormalities and with mental defect. Because of their precocious intravascular thrombosis, it seemed worth while to study their platelet stickiness, and it was found to be greatly increased in these children as compared to normal healthy children (Fig. 9) , and when homocystine was added in physiological concentrations to normal heparinized blood it resulted in greatly enhanced platelet stickiness (Fig. 10 ) . Thus, a natural experiment was presented, i.e. a disease with a welldefined metabolic background, in which platelet stickiness could be identified with, and attributed to, an abnormal biochemical constituent in the blood.
Abnormalities of Platelet Turnover. Mustard and his colleagues, using radioactive phosphorus to determine platelet turnover and survival in ischaemic heart disease, have shown that platelet turnover is abnormal in ischaemic heart disease , and that this change is adversely affected by a diet that is rich in fat and eggs , by fatty acids (Murphy et 1963), and by cigarette smoking (Mustard and Murphy, 1963a) , while heparin may produce a favourable effect (Mustard and Murphy, 1963b) .
In animal experiments, Mustard stressed the importance of the mechanical factor in vessel-wall thrombosis, which seems likely also to be important in people with ischaemic heart disease.
Chandler's Method. This has been used in ischaemic heart disease. Ardlie, Kinlough, and Schwartz (1966) found a tendency to abnormal in group.bmj.com on December 23, 2017 -Published by http://heart.bmj.com/ Downloaded from vitro thrombosis and platelet aggregation in cardiac infarction, and a decrease in the time for thrombus formation with cigarette smoking has been claimed by Engelberg (1965) , who suggested that this action was through the nicotine-induced release of adrenaline.
Platelet Aggregation in Ischaemic Heart Disease. Platelet aggregation, using Born's method, has been used to investigate a number of patients over the past two years (Bray, McDonald, and Davies, 1967a) . Fig. 11 shows the usual response in controls and in some patients; with the increasing doses of nucleotide the platelets aggregate together and disaggregate. There has been a tendency in the patients for higher peaks of aggregation than in the controls. Moreover, in some controls and in more patients, there was a phenomenon that we have termed "secondary platelet aggregation" (Bray and McDonald, 1966) . Fig. 12 shows an example; with intermediate doses of adenosine diphosphate the platelets aggregate together, and then, instead of spontaneously disaggregating, there is a phenomenon that may be termed "secondary aggregation", as shown on the middle curve A. In these subjects the platelets spontaneously aggregate again to form massive platelet clumps. These patients may well represent some in whom the thrombotic tendency is particularly prominent. Evidence now exists (C. Bray and L. McDonald, 1967, unpublished data) that there is a seasonal variation in aggregation both in the patients and in the controls, though at each period of the year the patients seem more sensitive in the response to adenosine diphosphate. An abnormal biochemical background has been shown to be associated with abnormal platelet behaviour, though not as yet in every instance in direct relation to ischaemic heart disease, and this must be further considered.
Adenosine Diphosphate (ADP). Born (1962) demonstrated that adenosine diphosphate was contained in the surface membrane of the blood platelet. Emmons et al. (1965a, b) showed that ADP-induced aggregation of the platelets is inhibited by dipyridamole, with a therapeutic possibility that will be considered later. Furthermore, Hampton and Mitchell (1966) have shown that ADP appears to alter the surface charge of platelets, and this is shown in a change in their electrokinetic response. After the addition of ADP, Seaman et al. (1967) have observed platelet microemboli in the living extracorporeal bovine eye, and Mustard et al. (1964) have noted platelet thromboses in the small coronary vessels of swine. Zucker and Borrelli (1962) have shown the effect of collagen in causing platelet clumping, and Schmid et al. (1962) have described the effect of thrombin. Clayton and Cross (1963) considered that the aggregation of platelets, whether induced by ADP, thrombin, or catecholamines, occurred through some final common path which is blocked by adenosine, and which therefore probably always involves ADP. Hampton and Mitchell (1966) Bygdeman, Eliasson, and Johnson (1966) have shown an increased sensitivity of the platelets to adenosine diphosphate after operations.
It seems probable that abnormal platelets are acting as an indicator system for a factor that is released from other blood cells during the preparation of platelet-rich plasma. HEART DISEASE Yudkin (1964) suggested that the dietary intake of sugar, which closely parallels that of fat intake, might be of vital importance in the genesis of the disease. Fig. 13 shows his findings with regard to the fat and sugar intake in 41 countries. He considered that statistics relating to the fat intake in ischaemic heart disease, or diabetes mellitus, in different populations, may therefore express only an indirect relation and that the causal relation may be with sugar.
CARBOHYDRATE METABOLISM IN IScHAEMIC
With regard to carbohydrate metabolism in ischaemic heart disease, numerous studies including those of Cohen and Shafrir (1965) have shown that glucose tolerance is abnormal in patients with ischaemic heart disease, which may be of interest in relation to Yudkin's (1964) findings. High levels of plasma insulin in ischaemic heart disease have been recorded by Peters and Hales (1965) (1965) found increased platelet stickiness in diabetic patients, which was enhanced by added glucose. The viscosity of the blood is also increased in diabetic patients (Skovborg et al., 1966) . Ostrander and Weinstein (1964) have demonstrated electrocardiographic changes involving the S-T segments and T waves after glucose ingestion, which were more frequent in patients with coronary heart disease than in apparently normal men.
FATTY ACIDS AND THROMBOSIS The relationship of the fatty acids may be important in thrombosis and in ischaemic heart disease. Soloff and Schwartz (1966) found that the fatty acid response to a glucose load was increased in ischaemic heart disease. Poole, Connor, and their colleagues (Connor and Poole, 1961; Connor, Hoak, and Warner, 1963; Poole, 1955) have shown that the long chain saturated fatty acids may enhance thrombosis, and that rapid lipid mobilization, leading to a high free fatty acid concentration, can result in thrombosis . Dole (1956) demonstrated an increase in fatty acids in the blood after adrenaline. The effects of fatty acids on blood coagulation and thrombosis have been studied by Connor, Hoak, and Warner (1965) . The results obtained from tests of the effects of various saturated fatty acids on the blood from 13 subjects are shown in Fig. 14 . The control thrombus formation time, with sodium chloride, averaged 8-3 minutes. Short chain fatty acids of chain length C6-C10 did not significantly accelerate thrombus formation time, but there was progressive shortening of the thrombus formation time as the chain length of the fatty acid increased from C10 onwards: C14 produced a . From Yudkin (1964) .
formation (see text). From Connor et al. (1965) . group.bmj.com on December 23, 2017 -Published by http://heart.bmj.com/ Downloaded from Lawson McDonald time of 5-3 minutes, palmitic, or C16, a time of 4-8 minutes; C18, C20, and C22 had especially great accelerating effects, with thrombus formation times as low as 2-4 minutes.
FIBRINOLYSIS AND THRoMBosis
Fibrinolysis and thrombolysis may be of extreme importance in ischaemic heart disease, but our own findings (Katz et al., 1963) , and those of others, which have been summarized by Fearnley (1965) , remain inconclusive. This may well be because of the still indifferent methods of examining these mechanisms. However, Ogston and Fullerton (1965) consider that fibrinolysis may be particularly active 5 to 8 hours after cardiac infarction, and that 8 to 10 days later there is no significant difference between the findings in patients and controls. Warren (1964) has suggested that the vascular endothelium releases plasminogen activator, with the rapid dissolution of thrombi on intact endothelium. Fearnley (1965) , in reviewing the subject, concluded that fibrinolysis and platelet behaviour might not be unrelated.
RHEOLOGY
The study of rheology in ischaemic heart disease awaits development. Three microrheological mechanisms in thrombogenesis appear to be important; these are the aggregation of red cells, the agglutination of platelets under a velocity gradient, and an increase in the internal rigidity of the red cells as a function of the pH (Dintenfass, 1965) . Increased viscosity after cardiac infarction has been described by Dintenfass (1964) and by Mayer (1964) .
HAEMATOCRIT AND RED CELLS
Increased haematocrit values with erythrocytosis have been reported in ischaemic heart disease by Burch and DePasquale (1962) , though this has been denied by Conley et al. (1964) . The liberation of material with platelet-like coagulant properties from the red cells, which could accelerate thrombosis, has been shown by Bradlow (1961) . Harrison and Mitchell (1966) , in studying the influences of red cells on platelet adhesiveness, found evidence that abnormal platelet stickiness might be related to red cell abnormalities, by the liberation of ADP from mechanically damaged erythrocytes.
BIOcHEMIcAL CORRELATIONS Possible correlations between the platelet abnormalities and the biochemical abnormalities, that have been described in ischaemic heart disease, have recently been studied (Bray et al., 1967b (French, MacFarlane, and Sanders, 1964) , shows part of the wall of a small vein in a hamster cheek pouch. The vein was not deliberately injured, but it was near to an injured artery and had probably been damaged during manipulation of the pouch. A platelet occupies a gap in the endothelium at an intercellular junction, and other platelets in the lumen are clearly seen to be sticking to it. This elegant study is in full agreement with the early work of Eberth and Schimmelbusch (1886) and Bizzozero (1882) , who recognized the important role that platelets played in the initiation of thrombosis.
In the coronary arteries of man it is understandably difficult to study in vivo the phenomena of platelet aggregation and platelet stickiness. But photographs of the ocular fundus that were obtained by Dr. Ross Russell (Ross Russell, 1961) in a case of monocular blindness may be analogous to similar events occurring in the coronary arterial tree. Fig.  16 shows an aggregation of platelets, the so-called white body, passing through a fundal arteriole. This was accompanied by transient blindness in the patient, and it might be considered that such temporary occlusion may have its counterpart in some patients with ischaemic heart disease and transient episodes of cardiac pain at rest. Some 10 to 15 minutes later a photograph of the same fundus shows the passage from the arteriole of the platelet white body, and at the time the patient's vision was unimpaired. Therefore, there is now abundant evidence of important changes in the circulating blood in patients after cardiac infarction. The question as to whether these changes occur before infarction, or subsequent to it, remains important, and it is easy to appreciate the difficulty in obtaining this information. But already there is considerable evidence that the circulating blood is abnormal in these patients before cardiac infarction occurs, in a way that is likely to predispose to thrombosis.
WHY HE CORONARY ARTmEs?
In the above respect it is often asked why it is that the coronary arteries thrombose and not arteries all over the body. However, patients with ischaemic heart disease have an abnormally high incidence of peripheral occlusive arterial disease (McDonald, 1953) ; thus more generalized arterial thrombosis is frequent in them. However, there are good reasons why, in a person liable to thrombose, the coronary arteries are so frequently the site of thrombosis. In the coronary arteries there is frequently at least one small critically placed atheromatous plaque, which may form the foreign contact that is important in the initiation of thrombosis. Otherwise the coronary arteries differ from others throughout the body in that their flow, in a major part of the coronary system, appears to occur in diastole as opposed to systole, and it is very likely that the flow is turbulent as opposed to laminar, which may enhance the tendency to thrombosis.
Evidence has been presented that the circulating blood is abnormal in patients with ischaemic heart disease, and particularly the blood platelets, and that metabolic reasons may account for these changes. Facts are accumulating to indicate that the abnormalities, which have been described, occur before the disease is clinically manifest. Sir George Pickering (1965) has put the situation in good perspective.
"The immediate cause of infarction of the heart is in most cases, though possibly not in all, a thrombus occluding a branch of a coronary artery, particularly the left anterior descending. The thrombus has a characterising structure-clumps ofplatelets fringed with leucocytes and interlaced with a fibrin meshwork which often contains red cells or the ghosts of red cells. As the thrombus ages the nuclei disappear, and it becomes more uniform in composition. Later it becomes organised and recanalised. The longer the interval between the clinical attack and death, the less likely is there to be a fresh thrombus and the more likely is there to be a characteristic plaque of intimal thickening producing coronary stenosis. A unitary view would imply that most stenosing plaques in coronary arteries represent the remnants of past thrombi of similar composition.
A working hypothesis of the nature of this disease is thus that it is a disease in which leucocyte-plateletfibrin thrombi occur episodically in arteries, especially at certain sites. These become organised and are incorporated into the intima as raised plaques. platelet stickiness, together with total serum cholesterol (Table III) (McDonald and Edgill, 1958) . The findings were highly significant both in the reduction of platelet stickiness and cholesterol, though the two changes appeared to be independent of one another. In this connexion, Geill, Hansen, and Lund (1960) found a reduction in thrombosis and embolism in a group of hospital patients having vegetable oils in their diet compared with others. Thus, dietary restriction may yet play an important part in the control of thrombosis. An interesting drug is the androsterone compound atromid (Thorp, 1962) which contains androsterone and ethyl p-chlorophenoxy isobutyrate. Atromid-S contains only ethyl p-chlorophenoxy isobutyrate, and no androsterone. Fig. 17 shows the changes in platelet stickiness, serum cholesterol, low density lipoprotein cholesterol, low density lipoprotein, Sf fractions 0-12 and 12-400 after atromid and atromid-S (Carson et al., 1966) . With both atromid and atromid-S there was a significant reduction in platelet stickiness, which was slightly more marked with atromid than with atromid-S.
In considering potentially antithrombotic measures phenindione indifferently affects abnormal platelet behaviour (L. McDonald and F. Love, 1964, unpublished observations), and heparin (McDonald and Edgill, 1961) has the great disadvantage of the need for parenteral administration. Diet may well prove to be important, and possibly even exercise. Ethyl p-chlorophenoxy isobutyrate is a compound that demands further study. And obviously any of these measures that appear worth while demand adequate trials, to determine whether the laboratory changes are accompanied by a reduction in the morbidityand mortality ofischaemic heart disease. Dipyridamole, or persantin, has been shown to affect platelet aggregation favourably (Emmons et al., 1965a) and may be used clinically. Other drugs that may be considered as potentially antithrombotic are adenosine (Bom and Cross, 1963; Clayton, Born, and Cross, 1963) , the antiserotonins, and phentolamine. However, it seems likely that existing compounds may well not be the final answer, but that current methods of study offer exciting new ways of finding a therapeutic answer to the prevention and treatment of coronary arterial thrombosis.
CONCLUSIONS
Thrombosis seems likely to be the final common path of a number of different aetiological factors, in the majority of patients with coronary heart disease.
The tendency to intravascular thrombosis, or its presence, is reflected by abnormal platelet behaviour, which seems likely to be an indicator of other abnormalities in the blood. In this, evidence is mounting that the role, particularly of the catecholamines, free fatty acids, and the red blood cells, may be of considerable importance.
Studies support but do not yet completely prove that disease of the arterial walls is associated with platelet changes and thrombus formation.
The predictive value of platelet changes in the development of ischaemic heart disease merits further study.
The correction of platelet abnormalities in ischaemic heart disease, by diet or by drugs, opens up new possibilities for antithrombotic as opposed to anticoagulant measures, both in the prophylaxis and in the management of the disease.
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